Cargando…
Prognostic Value of Cardiovascular Biomarkers in COVID-19: A Review
In early December 2019, the coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first emerged in Wuhan, China. As of May 10th, 2020, a total of over 4 million COVID-19 cases and 280,000 deaths have been reported globally, reflecting the raised infect...
Autores principales: | Aboughdir, Maryam, Kirwin, Thomas, Abdul Khader, Ashiq, Wang, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290838/ https://www.ncbi.nlm.nih.gov/pubmed/32403242 http://dx.doi.org/10.3390/v12050527 |
Ejemplares similares
-
The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19
por: Shi, Xingjuan, et al.
Publicado: (2021) -
Medical student and tutor perceptions on active learning strategies
por: Wang, Brian, et al.
Publicado: (2019) -
Evaluating the Prognostic Value of New Cardiovascular Biomarkers
por: Wood, Angela M., et al.
Publicado: (2009) -
The cellular uncertainty in thoracic aortic dissections: the roles of METTL3 and NOTCH1 on m6A in human aortic smooth muscle cells
por: Wright, Kelly, et al.
Publicado: (2023) -
Prognostic value of cardiac biomarkers in COVID-19 infection
por: Sheth, Aakash, et al.
Publicado: (2021)